Acute hepatitis C: Early, delayed or immediate treatment?;Hépatite aiguë C: Traitement immédiat, précoce ou différé?

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 2, 2004, Pages 126-128

  Lucidarme, Damien ^a,b   Filoche, Bernard ^a  

^a GROUPE HOSPITALIER DE L'INSTITUT CATHOLIQUE DE LILLE   (France)

^b Service de Pathologie Digestive   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PEGINTERFERON; RIBAVIRIN;

ACUTE DISEASE; DRUG EFFICACY; ERADICATION THERAPY; HEPATITIS C; HUMAN; LIVER BIOPSY; REVIEW; SEROCONVERSION; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 1642320063     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(04)94865-8     Document Type: Review

References (21)

1. Trinchet JC. Histoire naturelle de l'infection par le virus de l'hépatite C. Conférence de consensus. Gastroenterol Clin Biol 2002;26:B144-B153.
2. Conférence de consensus. Texte court. Hépatite C: dépistage et traitement. Gastroenterol Clin Biol 1997;21:45-9.
3. Grangé JD. Dépister et traiter l'hépatite virale aiguë C. Gastroenterol Clin Biol 2003;27:285-7.
4. Morin T, Pariente A. Hépatites aiguës C. Etude rétrospective de 62 cas. Gastroenterol Clin Biol 2002;26:994-1000.
5. Hofer H, Watkins-Riedel T, Janata O, Penner E, Holzmann H, Steindl-Munda P, et al. Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load. Hepatology 2003;37:60-4.
6. Gerlach JT, Diepolder HM, Zachoval R, Gruener NH, Jung MC, Ulsenheimer A, et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003;125: 80-8.
7. Vogel W, Graziadei I, Umlauf F, Datz C, Hackl F, Allinger S, et al. High-dose interferon alpha 2b treatment prevents chronicity in acute hepatitis C: a pilot study. Dig Dis Sci 1996;41:Suppl 81S-85S.
8. Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, et al. Treatment of acute hepatitis C with interferon alfa 2b. N Engl J Med 2001;345:1452-7.
9. Conférence de consensus. Traitement de l'hépatite C: Texte de Consensus. Gastroenterol Clin Biol 2002;26:B303-B311.
10. Santantonio T, Sinisi E, Guastadisegni A, Casalino C, Mazzola M, Gentile A. Natural course of acute hepatitis C: a long-term prospective study. Dig Liver Dis 2003;35:104-13.
11. Rocca P, Bailly F, Chevallier M, Chevallier P, Zoulim F, Trépo C. Etude de 16 cas d'hépatite C aiguë: essai de traitement précoce par l'interféron alpha 2-b et ribavirine. Gastroenterol Clin Biol 2003;27: 294-9.
12. Gordon SC. New insights into acute hepatitis C. Gastroenterology 2003;125:253-6.
13. Villano SA, Vlahov D, Nelson KE, Cohn S, Thomas DL. Persistance of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 1999;29:908-14.
14. Giuberti T, Marin MG, Ferrari C, Marchelli S, Schianchi C, Degli Antoni AM, et al. Hepatitis C virus viremia following clinical resolution of acute hepatitis C. J Hepatol 1994;20:666-71.
15. Larghi A, Zuin M, Crosignani A, Ribero ML, Pipia C, Battezzati PM, et al. Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies. Hepatology 2002; 36:993-1000.
16. Barrett S, Goh J, Coughlan B, Ryan E, Stewart S, Cockram A, et al. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut 2001;49:423-30.
17. Grangé JD, Nachury M, Schaeffer-Plumet J, Fouqueray B, Callard P, Amiot X. Traitement de l'hépatite virale aiguë C par interféron alpha quotidien. Rattrapage par adjonction de ribavirine (résumé). Gastroenterol Clin Biol 2002;26:A106.
18. Okuno T, Arai K, Shindo M. Efficacy of interferon for patients who develop chronic hepatitis C after an acute course of hepatitis. J Hepatol 1997;27:767-8.
19. Myers RP, Regimbeau C, Moussalli J, Ratziu V, Di Martino V, Thabut D, et al. Quelles sont les indications du traitement de l'hépatite C aiguë? Conférence de consensus. Gastroenterol Clin Biol 2002;26:B188-B193.
20. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar RO, et al. Peginterferon alfa-2b in combination with ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: results of a randomized trial. Lancet 2001;358:958-65.
21. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales F Jr, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-82.